Numans
2530.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$720M
Close$
$1.26
77.9% upside
Current Fair Value
77.9% upsideUndervalued by 77.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $720.00 Million |
|---|---|
| Enterprise Value | $446.29 Million |
| Dividend Yield | $0.03 (3.47%) |
| Earnings per Share | $0.01 |
| Beta | -0.4 |
| Outstanding Shares | 1,000,000,000 |
Return
| Return on Equity | 15.32% |
|---|---|
| Return on Assets | 14.10% |
| Return on Invested Capital | 2.58% |
Valuation & Multiples
| P/E Ratio | 7.88 |
|---|---|
| PEG | 0.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.78 |
| Enterprise Value to EBIT | 33.86 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Numans
50 employees
CEO: Ping Wang Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexa...